Astropharmacology — Part I —
Reblog: Originally Posted on August 11, 2014 — 4th post since the creation of this blog (August 10, 2014) —
Astropharmacology: name proposal for a scientific field devoted to understand why the names of magnificent planets are used as acronyms of poor quality clinical trials.
Part 1: Neptune and Saturn —
Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms (NEPTUNE)
Why I think the overall quality of this study is poor? PubMed Commons comment on NEPTUNE
A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH (SATURN)
Why I think the overall quality of this study is poor? PubMed Commons comments on SATURN
What will be discussed in part 2?
The gravity of Jupiter is inversely proportional to the quality of their homonymous clinical trial
A message to pharmaceutical companies
Think twice before choosing the name of a planet as an acronym for your next clinical trial.